Table 1.
Baseline characteristics of Child-Pugh B (7 and 8) patients with HCC treated with Microwave Ablation (MW) or Irreversible Electroporation (IRE)
| MW (N = 25) | IRE (N = 30) | P-Value | |
|---|---|---|---|
| Age | 60 (49–81) | 61 (51–75) | NS |
| Gender (Male/Female) | 23/2 | 28/2 | NS |
| Race | |||
| White | 25 | 27 | NS |
| African American | 0 | 3 | NS |
| Body mass index | 24.5 (21.3–34.2) | 24.8 (21.4–31.5) | NS |
| HCC Etiology | |||
| NASH | 4 | 2 | NS |
| Hepatitis | 7 | 9 | NS |
| ETOH | 12 | 14 | NS |
| Other | 2 | 5 | NS |
| Past medical history | |||
| Cardiac | 4 | 1 | |
| Vascular | 0 | 0 | |
| Pulmonary | 6 | 3 | |
| Diabetes | 3 (2 non-insulin) | 1 | |
| Smoking | 16 | 12 | |
| Hypertension | 21 | 26 | |
| Other | 18 | 13 | NS |
| Portal HTN | |||
| Yes | 19 | 27 | NS |
| Median MELD | 9 (6–14) | 10 (7–19) | NS |
| Prior Therapy | |||
| Surgical resection | 3 | 0 | |
| Prior Y-90 therapy | 6 | 7 | |
| Prior DEBDOX | 6 | 8 | |
| Prior therapy ablation | 2 | 2 | |
| Prior Nexavar | 4 | 4 | NS |
| Median AFP | 34 (2–2389) | 29 (3–1987) | NS |